At Genomenon, we recognize the power of actionable genetic insights in unlocking breakthroughs for rare and genetic diseases. We're thrilled to launch an initiative supporting variant analysts and researchers like you, driven to advance diagnosis and improve patient outcomes.
In support of upcoming disease awareness months, we're providing complimentary access to curated variant content on a subset of genes from Mastermind. This access to the literature in the database is only available to our Mastermind Professional users. However, with our Disease Awareness Initiative, we are aiming to enhance awareness to accelerate diagnosis and research of these diseases for anyone interested in this information.
This September for Muscular Dystrophy Awareness Month, we are providing access to curated variant information on a selection of genes directly associated with muscular dystrophy or related phenotypes. Variant detail on the following genes LMNA, CAPN3, BAG3, ERBB4, DPM3, EMD, FKRP, and RYR1, all of which have single nucleotide variants that are significant contributors to the disease, will be made available to all users for September.
By making this curated variant content available at no cost, we aim to drive awareness and discoveries that could positively impact the lives of those affected by muscular dystrophy.
Thank you for being a part of this journey. We’re excited to see the impact we can achieve together.
Genomenon is a leading genomic intelligence company dedicated to improving the quality of patients’ lives by uncovering the genomic drivers of genetic disease and cancer. Blending the power of AI with the genomic expertise, Genomenon simplifies complex genetic data into actionable insights for patient diagnosis and precision medicine development. The company’s solutions include software, data and curation and consulting services.
Learn more about Genomenon at genomenon.com and follow them on LinkedIn and Twitter.